Fresenius recalls drug vials due to glass specs

WASHINGTON (AP) - The American unit of German drugmaker Fresenius is recalling four lots of an injectable drug after finding particles of glass in some vials of the medication.

The recall applies to four lots of benztropine mesylate injection, which is used to treat Parkinson's disease and some movement side effects related to epilepsy drugs. The drug is manufactured by Allergy Laboratories Inc. and distributed by Fresenius Kabi. The products may also appear with APP or Nexus Pharmaceuticals listed as the manufacturer on the label. The recalled lot numbers are: 030712, 071212, 090512 and 111412.

Fresenius Kabi USA says no adverse reactions or customer complaints have been reported.

The company is asking health care professionals to return the products by calling the company at 1-866-716-2459.

___

On the Web: http://www.apppharma.com/our-products/product-updates3


(Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)

Top Stories

  • Making It Matter
    Cancer-fighting 14-year-old lives each day like it's the last with an army at his back

  • Plenty To Say
    Seahawk Richard Sherman had plenty to say Tuesday about the NFL and its 'hypocrisy'
ATTENTION COMMENTERS: We've changed our comments, but want to keep you in the conversation.
Please login below with your Facebook, Twitter, Google+ or Disqus account. Existing MyNorthwest account holders will need to create a new Disqus account or use one of the social logins provided below. Thank you.
comments powered by Disqus
Sign up for breaking news e-mail alerts from MyNorthwest.com
In the community
Do you know an exceptional citizen who has impacted and inspired others?
KIRO Radio and WSECU would like to recognize six oustanding citizens this year. Nominate them to be recognized and to receive a $2,000 charitable grant.